Human IFN-γ T cell ELISPOT kit - 2-plate

SKU
CT230-B2
All-inclusive ELISPOT kit with reagents and plates (192 determinations).
Format
2-plate
Price
€ 485
Documentation
Data sheet
Manual
SDS
Reactivity
Human
Category
T cell ELISPOT
Analyte
IFN-γ
Description
Our ELISPOT kits provide a complete, ready-to-use solution for reliable, high-performance ELISPOT assays. Each kit includes all essential components: coating and detection antibodies, streptavidin-HRP, TMB substrate, blocking stock solution, dilution buffer, Tween-20, and high-quality PVDF ELISPOT plates with lids and adhesive plate covers.
Description
IFN-γ is a potent immune regulating cytokine that plays a central role in activating the body’s defense against infections and malignant cells. By enhancing antigen presentation and boosting the activity of T cells and natural killer (NK) cells, IFN-γ drives strong antiviral and anti tumor responses. It is primarily produced by activated T helper 1 (Th1) cells, cytotoxic T cells, γδ T cells, NK cells, and natural killer T (NKT) cells, making it a key indicator of cellular immune activation in research and diagnostic applications.
Alternative names
IFN-γ, IFN-gamma, IFN-g, IFNg, interferon γ, interferon-γ, interferon-gamma, interferon gamma, INF-g, INF-gamma, immune interferon, Type II interferon
Gene ID
3458
Related Products

References

Authors, et al. Title Journal Year Volume Pages
Jiang Li Functional inactivation of EBV-specific T-lymphocytes in nasopharyngeal carcinoma: implications for tumor immunotherapy PLoS One 2007 2 e1122
Philippe Blancou Immunization of HLA class I transgenic mice identifies autoantigenic epitopes eliciting dominant responses in type 1 diabetes patients J Immunol 2007 178 7458-66
Jingxue Wang Lewis X oligosaccharides targeting to DC-SIGN enhanced antigen-specific immune response Immunology 2007 121 174-82
Liangen Chen B7-H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B J Immunol 2007 178 6634-41
Jeroen Stoop Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B Virology 2007 361 141-8
Roberto Mallone CD8+ T-cell responses identify beta-cell autoimmunity in human type 1 diabetes Diabetes 2007 56 613-21
Takaichi Hamano A single-nucleotide synonymous mutation in the gag gene controlling human immunodeficiency virus type 1 virion production J Virol 2007 81 1528-33
M Shi Hepatitis B virus (HBV) antigen-pulsed monocyte-derived dendritic cells from HBV-associated hepatocellular carcinoma patients significantly enhance specific T cell responses in vitro Clin Exp Immunol 2007 147 277-86
Jeroen Gerrits Stable T-cell reactivity after successful tapering of azathioprine in HLA-identical living-related kidney transplant recipients despite minor histocompatibility antigen mismatches Nephrol Dial Transplant 2007 22 353-61
Adriaan Bins Phase I clinical study with multiple peptide vaccines in combination with tetanus toxoid and GM-CSF in advanced-stage HLA-A*0201-positive melanoma patients J Immunother 2007 30 234-9